1st Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2013)

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

$20,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Expansion of naloxone access and utilization to prevent overdose mortality Prescription drug safety Reverse the federal funding ban on syringe exchange services

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Viral hepatitis testing and access to treatment Prevention of viral hepatitis infection in injection drug users Treatment of neonatal abstinence syndrome

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.